Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-18

FDA Approved: NITYR — Supplemental Application (Cycle Pharmaceuticals Ltd.)

View source ↗

Summary

FDA approved a supplemental application for NITYR (nitisinone) filed by Cycle Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITYR (Nitisinone)

Snippet

SUPPL AP for NITYR (NITISINONE)